Showing results (31-40 of 646) with videos related to
Sort By:
Pageof 65
Antimicrobial Agents and Chemotherapy|April 1, 1981
Moxalactam and cefazolin: comparative pharmacokinetics in normal subjectsW M Scheld, D A Spyker, G R Donowitz, et al.Antimicrobial Agents and Chemotherapy|February 1, 1982
Pharmacokinetics of cefaclor in renal failure: effects of multiple doses and hemodialysisD A Spyker, L L Gober, W M Scheld, et al.Antimicrobial Agents and Chemotherapy|December 1, 1980
Pharmacokinetics of moxalactam in subjects with various degrees of renal dysfunctionW K Bolton, W M Scheld, D A Spyker, et al.The Journal of Laboratory and Clinical Medicine|August 1, 1982
Cerebrospinal fluid prognostic indices in experimental pneumococcal meningitisW M Scheld, C Giampaolo, J Boyd, et al.American Journal of Clinical Pathology|October 1, 1981
A multivariate approach to prognostication in experimental bacterial meningitisC Giampaolo, W M Scheld, J Savory, et al.Antimicrobial Agents and Chemotherapy|September 1, 1985
Comparison of ceftriaxone and ampicillin plus chloramphenicol for the therapy of acute bacterial meningitisJ P Bryan, H Rocha, H R da Silva, et al.Reviews of Infectious Diseases|January 1, 1981
Intermittent or continuous therapy of experimental meningitis due to Streptococcus pneumoniae in rabbits: preliminary observations on the postantibiotic effect in vivoM A Sande, O M Korzeniowski, G M Allegro, et al.Infection and Immunity|April 1, 1979
Clearance of bacteria from cerebrospinal fluid to blood in experimental meningitisW M Scheld, T S Park, R G Dacey, et al.The Journal of Clinical Investigation|August 1, 1980
Cerebrospinal fluid outflow resistance in rabbits with experimental meningitis. Alterations with penicillin and methylprednisoloneW M Scheld, R G Dacey, H R Winn, et al.The American Journal of Medicine|May 15, 1984
Bacterial meningitis in the patient at risk: intrinsic risk factors and host defense mechanismsW M ScheldPageof 65